baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

BNP Paribas Knock-Out GRF/ DE000PG3E192 /

19/11/2024 18:20:57	Chg.-0.380	Bid18:27:53	Ask-	Underlying	Strike price	Expiration date	Option type
3.600EUR	-9.55%	3.590 Bid Size: 836	- Ask Size: -	GRIFOLS	6.9992 EUR	31/12/2078	Call

GlobeNewswire 31/07 GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HB...

GlobeNewswire 29/07 Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strength...

TeleTrader 08/07 Grifols family, Brookfield consider €5.5B takeover bid for Grifols

GlobeNewswire 01/07 Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years

Newsfile Corp 27/06 GRFS SHAREHOLDER ALERT: Johnson Fistel Announces Class Action Investigation of Grifols, S.A. for Pot...

GlobeNewswire 18/06 Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group

GlobeNewswire 17/06 Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...

GlobeNewswire 20/05 GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...

GlobeNewswire 18/04 Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...

GlobeNewswire 04/04 Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...

GlobeNewswire 31/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 29/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 25/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 23/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 22/03 Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...

GlobeNewswire 20/03 Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...

GlobeNewswire 15/03 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 01/03 GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...

GlobeNewswire 14/02 Grifols announces positive topline phase 3 fibrinogen clinical trial results

GlobeNewswire 12/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 11/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 08/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

GlobeNewswire 02/02 SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...

GlobeNewswire 02/02 Grifols S.A.: Company Investigated by the Portnoy Law Firm

GlobeNewswire 01/02 Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman

BNP Paribas Knock-Out GRF/ DE000PG3E192 /

If you wish to receive reply to your feedback, please provide your email address.